Can Clopidogrel reduce thrombotic risks in patients with metabolic syndrome, and how does it compare to other antiplatelet medications?
Sahil KapoorExplorer
Can Clopidogrel reduce thrombotic risks in patients with metabolic syndrome?
Share
Clopidogrel can reduce thrombotic risks in patients with metabolic syndrome. It’s less potent than newer agents like ticagrelor but offers fewer side effects than prasugrel.